These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 28629339)

  • 1. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?
    van Ginkel JH; Huibers MMH; Noorlag R; de Bree R; van Es RJJ; Willems SM
    Pathobiology; 2017; 84(3):115-120. PubMed ID: 27974721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.
    Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T
    Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.
    Pall AH; Jakobsen KK; Grønhøj C; von Buchwald C
    Acta Oncol; 2020 Jul; 59(7):845-850. PubMed ID: 32223478
    [No Abstract]   [Full Text] [Related]  

  • 6. Droplet digital polymerase chain reaction for detection and quantification of cell-free DNA TP53 target somatic mutations in oral cancer.
    Lin LH; Cheng HW; Liu CJ
    Cancer Biomark; 2022; 33(1):29-41. PubMed ID: 34366328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Payne K; Spruce R; Beggs A; Sharma N; Kong A; Martin T; Parmar S; Praveen P; Nankivell P; Mehanna H
    Head Neck; 2018 Jul; 40(7):1598-1604. PubMed ID: 29542214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated
    Kampel L; Feldstein S; Tsuriel S; Hannes V; Carmel Neiderman NN; Horowitz G; Warshavsky A; Leider-Trejo L; Hershkovitz D; Muhanna N
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma - A systematic review.
    Huang X; Leo P; Jones L; Duijf PHG; Hartel G; Kenny L; Vasani S; Punyadeera C
    Mutat Res Rev Mutat Res; 2024; 793():108477. PubMed ID: 37977279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
    Economopoulou P; Spathis A; Kotsantis I; Maratou E; Anastasiou M; Moutafi MK; Kirkasiadou M; Pantazopoulos A; Giannakakou M; Edelstein DL; Sloane H; Fredebohm J; Jones FS; Kyriazoglou A; Gavrielatou N; Foukas P; Panayiotides I; Psyrri A
    Oral Oncol; 2023 Apr; 139():106358. PubMed ID: 36871349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
    Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
    Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring.
    Yang X; Xu X; Zhang C; Ji T; Wan T; Liu W
    Oral Oncol; 2022 May; 128():105846. PubMed ID: 35358785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
    Bhambhani C; Sandford E; Haring CT; Brummel C; Tuck KL; Olesnavich M; Bhangale AD; Walline HM; Dermody SM; Spector ME; Chinn SB; Casper K; Mierzwa M; Swiecicki PL; Chad Brenner J; Tewari M
    Oral Oncol; 2023 Aug; 143():106436. PubMed ID: 37269557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
    Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays.
    Pritchard JJG; Hamilton G; Hurst CD; Fraser S; Orange C; Knowles MA; Jones RJ; Leung HY; Iwata T
    Urol Oncol; 2020 Sep; 38(9):737.e1-737.e10. PubMed ID: 32532529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay for PD-L1 Transcripts in Circulating Tumor Cells.
    Strati A; Zavridou M; Economopoulou P; Gkolfinopoulos S; Psyrri A; Lianidou E
    Clin Chem; 2021 Mar; 67(4):642-652. PubMed ID: 33421061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.
    Flach S; Howarth K; Hackinger S; Pipinikas C; Ellis P; McLay K; Marsico G; Forshew T; Walz C; Reichel CA; Gires O; Canis M; Baumeister P
    Br J Cancer; 2022 May; 126(8):1186-1195. PubMed ID: 35132238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
    Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
    N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
    Tzanikou E; Haselmann V; Markou A; Duda A; Utikal J; Neumaier M; Lianidou ES
    Clin Chem Lab Med; 2020 Oct; 58(11):1799-1807. PubMed ID: 31953992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.